Actively Recruiting
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-02-09
400
Participants Needed
7
Research Sites
469 weeks
Total Duration
On this page
Sponsors
M
Memorial Sloan Kettering Cancer Center
Lead Sponsor
P
Phenogen Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare.
CONDITIONS
Official Title
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patient, age 25 years or older
- Clinically confirmed BRCA1 or BRCA2 deleterious mutation from full sequence or targeted genetic testing
- No personal history of breast cancer
- Fluent in English to complete surveys
You will not qualify if you...
- Previous receipt of any prophylactic mastectomy
- Major psychiatric illness or cognitive impairment that would prevent study participation
- Inability to comply with study procedures as determined by study staff
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Dana Farber Cancer Institute (Data Collection Only)
Boston, Massachusetts, United States, 02115
Actively Recruiting
2
Memorial Sloan-Kettering at Basking Ridge
Basking Ridge, New Jersey, United States, 07920
Actively Recruiting
3
Memorial Sloan Kettering Commack
Commack, New York, United States, 11725
Actively Recruiting
4
Memorial Sloan Kettering Westchester
Harrison, New York, United States, 10604
Actively Recruiting
5
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
6
Memorial Sloan Kettering Nassau
Uniondale, New York, United States, 11553
Actively Recruiting
7
Abramson Cancer Center at University of Pennsylvania Medical Center (Data Collection Only)
Philadelphia, Pennsylvania, United States, 19104-4283
Actively Recruiting
Research Team
J
Jada Hamilton, PhD, MPH
CONTACT
M
Mark Robson, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here